查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990117

食道支架市场：按产品类型、应用和最终用户分類的全球市场预测 - 2026-2032 年

Esophageal Stents Market by Product Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，食道支架市场价值将达到 1.6992 亿美元，到 2026 年将成长至 1.7969 亿美元，到 2032 年将达到 2.6342 亿美元，复合年增长率为 6.46%。

主要市场统计数据
基准年 2025 1.6992亿美元
预计年份：2026年 1.7969亿美元
预测年份 2032 2.6342亿美元
复合年增长率 (%) 6.46%

在器械设计创新、手术环境和相关人员决策因素方面，阐明食道支架的临床意义和商业性背景。

食道支架已成为阻塞性和穿孔性食道疾病多学科诊疗路径中的核心治疗方法，根据临床情况，弥合了安宁疗护、根治性治疗和临时干预之间的差距。材料科学、输送系统和支架设计方面的最新创新拓宽了临床医生的选择范围，并优化了手术流程；与此同时，不断变化的医保报销模式和门诊环境的改变正在重塑医疗服务的提供方式。随着器械的不断发展，从介入性胃肠病学家到医院供应链管理人员等相关人员都面临着临床疗效、手术效率和长期耐用性之间复杂的权衡取舍。

材料、输送系统、监管重点和临床环境的转变如何共同重新定义食道支架的临床实践和商业模式。

食道支架领域正经历一场变革，其驱动力来自于技术的进步、临床实践的不断发展以及供应链的现代化。材料科学的进步加速了具有更佳径向力控制和贴合度的自膨胀金属支架的普及应用，而生物可降解聚合物的进步则为临时支架提供了新的选择，从而减少了取出支架的需要。输送系统的微型化和透视成像的改善在许多情况下缩短了手术时间，使得更多手术能够从住院手术室转移到门诊手术中心和专科诊所。因此，临床医生可以提供创伤更小、恢復更快的治疗方案，这正在重塑转诊模式以及与保险公司的沟通方式。

对美国对进口医疗设备组件和成品征收关税措施所造成的营运、临床进入和采购影响进行全面评估。

美国2025年实施的新关税措施引发了食道支架整个价值链的一系列营运和战略应对措施，影响范围涵盖从原材料采购到医院采购委员会的方方面面。关税带来的成本压力促使医疗设备製造商重新评估其采购管道，并探索替代材料和国内供应合约以降低风险。一些公司加快了与优选合作伙伴整合组件采购的步伐，以维持价格和前置作业时间的可预测性；而另一些公司则正在分阶段进行产品重新设计，以减少对关税敏感型原材料的依赖。

细分市场对产品设计、临床选择标准和采购方法的影响，源自于产品、应用和最终用户之间的详细差异。

市场区隔洞察表明，为了最大限度地提高临床适用性和商业性吸引力，器械策略和商业化必须根据产品设计、临床适应症和终端用户环境进行精细调整。从可生物降解平台到塑胶结构和自膨式金属支架，每种产品类型都有其独特的临床权衡。可生物降解支架适用于临时支撑场景，避免移除可带来临床效益。同时，由聚乙烯和聚氨酯组成的塑胶支架在成本、植入便利性或特定机械性能优先考虑的特定细分市场中仍然发挥作用。自膨式金属包覆器械有镍钛合金和不銹钢两种材质，其适应性和径向强度存在差异，这会影响瘻管闭合和恶性狭窄缓解的选择。相反，自膨式金属裸支架（同样有镍钛合金和不銹钢两种材质）在组织浸润和长期通畅性对临床决策至关重要时仍然是重要的选择。

美洲、欧洲、中东和非洲以及亚太地区的区域法规结构、支付方结构和供应链现实如何影响采用和商业化策略？

区域趋势对食道支架的法规结构、报销机制和临床应用模式有显着影响，因此，各地区的製造商和服务供应商需要采取差异化的策略。在美洲，临床上对微创介入治疗的重视以及成熟的报销体係正在推动先进自膨式金属支架的应用，并将支架相关的疗效数据纳入基于价值的合约谈判中。同时，该地区的供应链中断和复杂的关税问题促使製造商与大型医院系统加强合作，以确保供应的连续性，并使合约条款与手术量相符。

透过材料创新、数据驱动的临床支持和影响合约取得和临床医生采纳的策略性商业性伙伴关係实现竞争差异化。

企业格局正因产品创新、策略伙伴关係以及对供应链和监管要求的快速应对力而重塑。主要企业正透过投资材料科学、优化镍钛诺和不銹钢合金的製程以实现更精细的径向力分布，以及推进用于临时支架植入的可生物降解聚合物配方，来打造差异化优势。此外，多家公司正透过提供培训项目、数位化手术规划工具和基于註册的疗效追踪，拓展其价值提案，超越单纯的器械供应，从而加速产品在临床环境中的应用，并支持与支付方进行价值对话。

为製造商和医疗保健系统领导者提供切实可行的优先步骤，以加强证据产生、实现供应链多元化，并使商业模式与临床要求保持一致。

行业领导者应采取多管齐下的方法，整合临床证据的积累、供应链的韧性以及灵活的商业性合同，以维持增长并保障利润率。首先，他们应优先进行可靠的真实世界证据（RWE）倡议和上市后註册研究，以记录器械在关键适应症（例如吻合口、消化道和放射相关良性狭窄，以及恶性阻塞和瘻管的治疗）中的表现。这些数据资产将有助于加强与支付方的谈判，并促进在以治疗结果衡量作为保险覆盖要求的环境中推广应用。其次，他们应审查筹资策略，以减少对单一国家的依赖，并制定紧急时应对计画，包括合格的替代供应商、区域库存中心以及允许在不影响临床性能的前提下替换对关税敏感的组件的设计方案。

我们采用透明的多来源调查方法，结合对临床医生的访谈、对监管和临床文献的审查以及使用三角测量法的供应链分析，得出检验的战略见解。

本研究整合了一种结构化的调查方法，结合了来自一手定性研究的洞见、系统的二手分析以及严谨的检验，从而得出可靠的结论和建议。此方法首先进行针对性的一手研究，包括对介入性胃肠病学家、医院采购经理、临床试验主要研究者和高级法规事务专业人员进行深入访谈。这提供了关于器械性能、临床工作流程和采购要求的第一手观点。此外，也透过对同侪审查的临床文献、监管申报文件、器械标籤和会议论文集进行系统性回顾，来阐明器械类型、材料特性和发展趋势，从而补充上述一手资讯。

整合临床、营运和商业性需求，领导者必须整合这些需求，以确保在不断发展的食道支架市场中保持可持续的竞争优势

总之，食道支架领域正处于一个转折点，材料创新、低急性护理机构的兴起以及对临床疗效日益增长的期望交织在一起，正在重塑临床实践和商业策略。能够针对特定临床适应症设计产品的製造商——无论是用于治疗某些良性狭窄的临时性可生物降解支架，还是用于治疗恶性梗阻和瘻管的坚固金属结构——都将更有能力满足临床医生的需求，并经受住支付方的严格审查。同时，供应链的韧性和灵活的商业模式对于在应对不断变化的贸易政策和采购压力的同时，维持医疗服务的可及性至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 食道支架市场：依产品类型划分

  • 可生物降解
  • 塑胶
    • 聚乙烯
    • 聚氨酯
  • 自膨胀金属涂层
    • 镍钛诺
    • 不銹钢
  • 自膨胀金属（未涂层）
    • 镍钛诺
    • 不銹钢

第九章 食道支架市场：依应用领域划分

  • 良性狭窄
    • 吻合口狭窄
    • 消化性狭窄
    • 放射学狭窄
  • 瘻管/穿孔
  • 恶性狭窄

第十章 食道支架市场：依最终用户划分

  • 门诊手术中心
  • 医院
    • 私立医院
    • 公立医院
  • 专科诊所

第十一章 食道支架市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十二章 食道支架市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十三章 食道支架市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十四章：美国食道支架市场

第十五章：中国食道支架市场

第十六章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Advin Healthcare Private Limited
  • Boston Scientific Corporation
  • Changzhou Health Microport Medical Device Co., LTD.
  • Cook Group Incorporated
  • ELLA-CS, sro
  • ENDO-FLEX GmbH. by Medi-Globe Group
  • Leufen Medical by bess AG.
  • MITECH.
  • Medorah Meditek Pvt. Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MICRO-TECH（Nanjing）Co., Ltd.
  • Micro-Tech Endoscopy
  • Mitra Industries Pvt. Ltd.
  • Olympus Corporation
  • S&G Biotech Inc.
  • TAEWOONG MEDICAL Co., Ltd
  • WL Gore & Associates, Inc.
Product Code: MRR-5D693B46C01D

The Esophageal Stents Market was valued at USD 169.92 million in 2025 and is projected to grow to USD 179.69 million in 2026, with a CAGR of 6.46%, reaching USD 263.42 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 169.92 million
Estimated Year [2026] USD 179.69 million
Forecast Year [2032] USD 263.42 million
CAGR (%) 6.46%

Framing the clinical importance and commercial context of esophageal stents amid innovations in device design, procedural settings, and stakeholder decision drivers

Esophageal stents have become a cornerstone intervention within multidisciplinary care pathways for obstructive and perforative esophageal disease, bridging palliation, definitive management, and temporizing measures depending on clinical context. Recent innovations in materials science, delivery systems, and stent design have expanded clinician choice and refined procedural workflows, while evolving reimbursement models and outpatient procedural settings have shifted how care is delivered. As devices evolve, stakeholders from interventional gastroenterologists to hospital supply chain leaders face complex trade-offs between clinical performance, procedural efficiency, and long-term durability.

This introduction synthesizes current device typologies, common clinical indications, and the macroeconomic and regulatory dynamics that shape procurement and adoption. It sets the stage for a deeper examination of transformative shifts in device technology, the ramifications of emergent trade policies, segmentation-driven commercial implications, regional variation in uptake, competitive behaviors among manufacturers, and pragmatic recommendations for leaders. Throughout, the emphasis is on translating technical developments into operational and strategic insights that support optimal patient outcomes and sustainable commercial models.

How converging advances in materials, delivery systems, regulatory focus, and care-site migration are redefining clinical practice and commercial models for esophageal stents

The landscape for esophageal stents is undergoing transformative shifts driven by technological refinement, clinical practice changes, and supply chain modernization. Advances in material engineering have accelerated the adoption of self-expanding metallic devices with improved radial force control and conformability, and simultaneous progress in biodegradable polymers is creating alternative pathways for temporary scaffolding that reduce the need for device retrieval. Delivery system miniaturization and enhanced fluoroscopic visibility have shortened procedural time in many cases, enabling more procedures to migrate from inpatient operating rooms to ambulatory surgical centers and specialty clinics. Consequently, clinicians can offer less invasive options with faster recovery, which reshapes referral patterns and payer conversations.

Alongside device innovation, regulatory emphasis on post-market surveillance and real-world evidence has heightened manufacturers' focus on longitudinal clinical outcomes and device registries. Health systems increasingly require demonstrable value through measurable reductions in complication rates and reintervention, prompting manufacturers to invest in data infrastructure and clinical partnerships. On the commercial front, consolidation among providers and payers is concentrating purchasing power, encouraging manufacturers to develop bundled-service propositions and flexible contracting models. Meanwhile, digital health tools that support pre-procedural planning, intra-procedural guidance, and remote follow-up are emerging as differentiators that align clinical utility with operational efficiencies, further accelerating the shift toward integrated care delivery models.

Assessment of the comprehensive operational, clinical access, and procurement consequences arising from United States tariff measures on imported medical device components and finished devices

The introduction of new tariff measures in the United States in 2025 has prompted a series of operational and strategic responses across the esophageal stent value chain, with effects felt from raw-material procurement to hospital purchasing committees. Tariff-related cost pressures have encouraged device manufacturers to reassess sourcing footprints and to explore alternative materials or domestic supply agreements to mitigate exposure. In some cases, companies have accelerated consolidation of component sourcing with preferred partners to preserve predictability in price and lead time, while others have pursued incremental redesigns that reduce reliance on tariff-sensitive inputs.

Clinicians and health system procurement teams have experienced downstream impacts through extended lead times and altered vendor negotiations, which in turn influence inventory management and procedural scheduling. To preserve access and keep procedures on schedule, hospitals have adopted a range of strategies including multi-vendor contracting, strategic inventory buffers, and closer collaboration with clinical teams to prioritize device allocation for high-acuity cases. Simultaneously, payers and hospital finance leaders are reassessing procedure cost structures and reimbursement assumptions, leading to renewed emphasis on demonstrable clinical benefit and total cost of care. These cumulative adjustments underscore the need for cross-functional coordination, with supply chain, clinical leadership, and commercial teams working together to maintain continuity of care while navigating elevated import-related costs and heightened regulatory scrutiny.

Segment-specific implications for product design, clinical selection criteria, and procurement approaches derived from detailed product, application, and end-user distinctions

Insight into segmentation reveals that device strategy and commercialization must be finely tailored to product design, clinical indication, and end-user environment to maximize clinical fit and commercial traction. Product type distinctions-ranging from biodegradable platforms to plastic constructs and self-expanding metallic options-carry unique clinical trade-offs. Biodegradable stents are positioned for temporary scaffolding scenarios where avoidance of removal confers clinical advantages, whereas plastic stents such as those constructed from polyethylene or polyurethane continue to serve defined niches where cost, ease of deployment, or specific mechanical properties are prioritized. Self-expanding metallic covered devices, available in nitinol and stainless steel variants, tend to offer differences in conformity and radial force that influence selection for sealing fistulae or palliation of malignant strictures, while self-expanding metallic uncovered versions, also in nitinol and stainless steel, remain relevant when tissue ingrowth and long-term patency considerations dominate clinical decision making.

Application-focused segmentation further clarifies clinical pathways and commercial messaging. Benign strictures-subdivided into anastomotic, peptic, and radiation-related etiologies-require particular attention to long-term remodeling and the risk-benefit profile of temporary versus permanent scaffolds. Fistula and perforation cases demand rapid sealing and high immediate radial support to prevent contamination and facilitate healing, while malignant strictures prioritize palliation, luminal patency, and quality-of-life outcomes. End-user segmentation highlights differences in procedural setting and procurement complexity: ambulatory surgical centers may prioritize devices optimized for efficiency and rapid turnover, hospitals-both private and public-must balance broad therapeutic portfolios and budget cycles, and specialty clinics often focus on niche procedural volumes and clinician preference patterns. Taken together, these intersecting segmentation lenses indicate that successful product strategies are those that align material science and design with specific clinical indications and the operational realities of the deploying institution.

How regional regulatory frameworks, payer structures, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific shape adoption and commercialization strategies

Regional dynamics exert a strong influence on regulatory frameworks, reimbursement practices, and clinical adoption patterns for esophageal stents, requiring manufacturers and service providers to adopt regionally differentiated strategies. In the Americas, the clinical emphasis on minimally invasive interventions and mature reimbursement systems has supported the adoption of advanced self-expanding metallic devices and the integration of device-related outcomes data into value-based contracting discussions. Conversely, supply chain disruptions and tariff-related complexities in the region have prompted closer collaboration between manufacturers and large hospital systems to ensure continuity of supply and to align contracting terms with procedural volumes.

Across Europe, the Middle East & Africa, regulatory heterogeneity and variable healthcare funding models shape adoption in distinct ways. In parts of Europe, strong registries and health technology assessment processes raise the bar for clinical evidence and post-market follow-up, favoring manufacturers that can demonstrate longitudinal outcomes and cost-effectiveness. In several Middle Eastern and African markets, infrastructural constraints and centralized procurement mechanisms influence device mix and pricing dynamics, often creating opportunities for durable, lower-cost solutions and for partnerships that include clinician training and support. In the Asia-Pacific region, rapid hospital capacity expansion, increasing procedural volumes, and investments in domestic manufacturing capacity are accelerating uptake of both metallic and biodegradable platforms, with local regulatory pathways and partnerships frequently shaping the speed and nature of market entry. Across all regions, evolving patient demographics and rising incidence of esophageal disease underscore persistent demand, but successful market strategies require nuanced alignment with regional clinical practice patterns, regulatory expectations, and procurement ecosystems.

Competitive differentiation through materials innovation, data-enabled clinical support, and strategic commercial partnerships that influence contract wins and clinician adoption

Company-level dynamics are being reshaped by a combination of product innovation, strategic partnerships, and operational responsiveness to supply chain and regulatory demands. Leading manufacturers are differentiating through investments in material science, optimizing nitinol and stainless steel alloy processes to achieve refined radial force profiles, and advancing biodegradable polymer formulations for temporary stenting applications. In addition, several firms are expanding their value propositions beyond pure device supply by offering training programs, digital procedural planning tools, and registry-based outcome tracking that enhance clinical adoption and support payer conversations on value.

Competitive positioning also reflects different go-to-market models: some companies emphasize direct relationships with large hospital systems and integrated health networks, while others leverage distributor channels and partnerships with local firms to navigate complex regulatory and procurement landscapes. Strategic collaborations between device manufacturers and diagnostic or imaging technology providers are becoming more common, enabling combined offerings that improve placement precision and reduce procedure time. At the same time, mid-sized firms and new entrants often compete on niche innovation, speed to market in specific regulatory jurisdictions, and agility in customizing products for distinct clinical segments. Manufacturing footprint decisions, supplier diversification, and commitment to quality systems and post-market surveillance remain decisive factors affecting credibility and long-term contract viability.

Practical and prioritized steps for manufacturers and health system leaders to strengthen evidence generation, diversify supply chains, and align commercial models with clinical site requirements

Industry leaders should adopt a multi-dimensional approach that integrates clinical evidence generation, supply chain resilience, and commercially flexible contracting to sustain growth and protect margins. First, prioritize robust real-world evidence initiatives and post-market registries that capture device performance across key indications such as anastomotic, peptic, and radiation-related benign strictures, as well as malignant obstruction and fistula management. These data assets will strengthen payer negotiations and facilitate adoption in settings where outcomes measurement is a prerequisite for formulary inclusion. Second, reassess sourcing strategies to reduce exposure to single-country supply chains, and develop contingency plans that include qualified alternative suppliers, localized inventory hubs, and design options that permit substitution of tariff-sensitive components without undermining clinical performance.

Third, tailor commercial models to end-user needs by offering device portfolios and service bundles suited to ambulatory surgical centers, private and public hospitals, and specialty clinics. This includes flexible pricing, training and proctoring packages, and outcome-based contracting where appropriate. Fourth, invest in clinician education and digital tools that enhance procedural efficiency and placement accuracy, thereby improving clinical outcomes and demonstrating value to payers. Finally, engage proactively with regulatory authorities and health technology assessment bodies to align evidence generation plans and to expedite market access in priority geographies. Taken together, these actions will enable manufacturers and health systems to navigate evolving trade environments, meet clinician expectations, and deliver sustainable patient-centered care.

A transparent multi-source methodology combining clinician interviews, regulatory and clinical literature review, and triangulated supply chain analysis to produce validated strategic insights

This research synthesizes a structured methodology that blends primary qualitative insights, systematic secondary analysis, and rigorous triangulation to ensure credible conclusions and actionable recommendations. The approach begins with targeted primary engagements including in-depth interviews with interventional gastroenterologists, hospital procurement leads, clinical trial investigators, and senior regulatory affairs professionals to capture frontline perspectives on device performance, clinical workflows, and procurement imperatives. These primary inputs are complemented by a systematic review of peer-reviewed clinical literature, regulatory filings, device labeling, and conference proceedings to map device typologies, material properties, and outcome trends.

Data synthesis employs triangulation across sources to reconcile differences and to surface consistent themes, with attention to geographic variability in regulatory requirements and procurement practices. Segmentation frameworks are validated against clinician- and institution-level feedback to ensure practical relevance, and supply chain analyses incorporate publicly available trade data and verified supplier disclosures. Limitations are acknowledged: clinical practice variation and evolving regulatory guidance can change the operational landscape, and proprietary contract terms between manufacturers and large customers are not always fully transparent. Throughout, ethical standards for research are observed, and claims are grounded in verified evidence and expert input to support defensible, actionable insights.

Synthesis of clinical, operational, and commercial imperatives that leaders must integrate to secure durable advantage in the evolving esophageal stent landscape

In conclusion, the esophageal stent sector is at an inflection point where material innovation, procedural migration to lower-acuity sites, and heightened expectations for real-world outcomes converge to reshape clinical practice and commercial strategy. Manufacturers that align product design with specific clinical indications-whether temporary biodegradable scaffolding for select benign strictures or robust metallic constructs for malignant obstruction and fistula-will be better positioned to satisfy clinician needs and payer scrutiny. Concurrently, supply chain resilience and adaptive commercial models are critical to navigate trade policy shifts and procurement pressures while preserving access to care.

Looking ahead, strategic emphasis on evidence generation, clinician support, and regional market tailoring will determine which organizations capture sustainable advantage. Stakeholders who prioritize interoperability between device performance data and health system value frameworks, while maintaining flexible manufacturing and sourcing strategies, will be best placed to respond to evolving clinical demands and regulatory expectations. Ultimately, the pathway to durable success in this sector requires integrated planning across R&D, regulatory affairs, supply chain, and commercial teams to deliver devices that demonstrably improve patient outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Esophageal Stents Market, by Product Type

  • 8.1. Biodegradable
  • 8.2. Plastic
    • 8.2.1. Polyethylene
    • 8.2.2. Polyurethane
  • 8.3. Self Expanding Metallic Covered
    • 8.3.1. Nitinol
    • 8.3.2. Stainless Steel
  • 8.4. Self Expanding Metallic Uncovered
    • 8.4.1. Nitinol
    • 8.4.2. Stainless Steel

9. Esophageal Stents Market, by Application

  • 9.1. Benign Stricture
    • 9.1.1. Anastomotic Stricture
    • 9.1.2. Peptic Stricture
    • 9.1.3. Radiation Stricture
  • 9.2. Fistula Perforation
  • 9.3. Malignant Stricture

10. Esophageal Stents Market, by End User

  • 10.1. Ambulatory Surgical Center
  • 10.2. Hospital
    • 10.2.1. Private Hospital
    • 10.2.2. Public Hospital
  • 10.3. Specialty Clinic

11. Esophageal Stents Market, by Region

  • 11.1. Americas
    • 11.1.1. North America
    • 11.1.2. Latin America
  • 11.2. Europe, Middle East & Africa
    • 11.2.1. Europe
    • 11.2.2. Middle East
    • 11.2.3. Africa
  • 11.3. Asia-Pacific

12. Esophageal Stents Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Esophageal Stents Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. United States Esophageal Stents Market

15. China Esophageal Stents Market

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025
  • 16.5. Advin Healthcare Private Limited
  • 16.6. Boston Scientific Corporation
  • 16.7. Changzhou Health Microport Medical Device Co., LTD.
  • 16.8. Cook Group Incorporated
  • 16.9. ELLA-CS, s.r.o.
  • 16.10. ENDO-FLEX GmbH. by Medi-Globe Group
  • 16.11. Leufen Medical by bess AG.
  • 16.12. M.I.TECH.
  • 16.13. Medorah Meditek Pvt. Ltd.
  • 16.14. Medtronic plc
  • 16.15. Merit Medical Systems, Inc.
  • 16.16. MICRO-TECH (Nanjing) Co., Ltd.
  • 16.17. Micro-Tech Endoscopy
  • 16.18. Mitra Industries Pvt. Ltd.
  • 16.19. Olympus Corporation
  • 16.20. S&G Biotech Inc.
  • 16.21. TAEWOONG MEDICAL Co., Ltd
  • 16.22. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ESOPHAGEAL STENTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ESOPHAGEAL STENTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 11. CHINA ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY ANASTOMOTIC STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PEPTIC STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY RADIATION STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY FISTULA PERFORATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY MALIGNANT STRICTURE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY SPECIALTY CLINIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 124. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 126. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. MIDDLE EAST ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 132. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 133. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 135. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. AFRICA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 150. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 151. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 152. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 154. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. ASEAN ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 156. GCC ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 158. GCC ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 159. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 160. GCC ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 161. GCC ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. GCC ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 163. GCC ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. GCC ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPEAN UNION ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 174. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 177. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 178. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 179. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 181. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. BRICS ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 183. G7 ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. G7 ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. G7 ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 186. G7 ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 187. G7 ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 188. G7 ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. G7 ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 190. G7 ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 192. NATO ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. NATO ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. NATO ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 195. NATO ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 196. NATO ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 197. NATO ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. NATO ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 199. NATO ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. NATO ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL ESOPHAGEAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 203. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 205. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 206. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 207. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 211. CHINA ESOPHAGEAL STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY PLASTIC, 2018-2032 (USD MILLION)
  • TABLE 214. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC COVERED, 2018-2032 (USD MILLION)
  • TABLE 215. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY SELF EXPANDING METALLIC UNCOVERED, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY BENIGN STRICTURE, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA ESOPHAGEAL STENTS MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)